Literature DB >> 10204447

Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection.

F J Ramos-Gomez1, C Flaitz, P Catapano, P Murray, A R Milnes, A Dorenbaum.   

Abstract

The criteria for diagnosis of HIV-related oral lesions in adults are well established, but corresponding criteria in the pediatric population are not as well defined. The Collaborative Workgroup on the Oral Manifestations of Pediatric HIV infection reached a consensus, based upon available data, as to the presumptive and definitive criteria to diagnose the oral manifestations of HIV infection in children. Presumptive criteria refer to the clinical features of the lesions, including signs and symptoms, whereas definitive criteria require specific laboratory tests. In general, it is recommended that definitive criteria be established whenever possible. Orofacial manifestations have been divided into three groups: 1) those commonly associated with pediatric HIV infection; 2) those less commonly associated with pediatric HIV infection; and 3) those strongly associated with HIV infection but rare in children. Orofacial lesions commonly associated with pediatric HIV infection include candidiasis, herpes simplex infection, linear gingival erythema, parotid enlargement, and recurrent aphthous stomatitis. In contrast, orofacial lesions strongly associated with HIV infection but rare in children include Kaposi's sarcoma, non-Hodgkin's lymphoma, and oral hairy leukoplakia. Treatment recommendations, specific for this age group, have been included for some of the more common HIV-related orofacial manifestations.

Entities:  

Mesh:

Year:  1999        PMID: 10204447

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  24 in total

1.  Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia.

Authors:  Paulo Henrique Braz-Silva; Nathalie Pepe Medeiros de Rezende; Karem Lopez Ortega; Raimunda Telma de Macedo Santos; Marina Helena Cury Gallottini de Magalhães
Journal:  Head Neck Pathol       Date:  2008-02-08

2.  Oral lesions among HIV-infected children on antiretroviral treatment in West Africa.

Authors:  David Meless; Boubacar Ba; Malick Faye; Jean-Serge Diby; Serge N'zoré; Sébastien Datté; Lucrèce Diecket; Clémentine N'Diaye; Edmond Addi Aka; Kouadio Kouakou; Abou Ba; Didier Koumavi Ekouévi; François Dabis; Caroline Shiboski; Elise Arrivé
Journal:  Trop Med Int Health       Date:  2014-01-06       Impact factor: 2.622

3.  Orofacial manifestations in HIV positive children attending Mildmay Clinic in Uganda.

Authors:  Juliet Nabbanja; Sheba Gitta; Stefan Peterson; Charles Mugisha Rwenyonyi
Journal:  Odontology       Date:  2012-02-24       Impact factor: 2.634

4.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

5.  Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.

Authors:  M S Duggal; H Abudiak; C Dunn; H J Tong; T Munyombwe
Journal:  Eur Arch Paediatr Dent       Date:  2010-10

Review 6.  Oral ranula in an HIV-positive patient: case report and literature review.

Authors:  Andrew Jon Kinshuck; Marianne Schober; George Kokai; Ray Clarke
Journal:  BMJ Case Rep       Date:  2012-07-10

7.  Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients.

Authors:  Elaine Blignaut
Journal:  Mycopathologia       Date:  2007-02-12       Impact factor: 2.574

8.  Oral manifestations in HIV-infected individuals from Thailand and Cambodia.

Authors:  P A Reichart; P Khongkhunthian; C Bendick
Journal:  Med Microbiol Immunol       Date:  2003-01-18       Impact factor: 3.402

9.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Authors:  M Navazesh; R Mulligan; R Karim; W J Mack; S Ram; H Seirawan; J Greenspan; D Greenspan; J Phelan; M Alves
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

Review 10.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.